The Prague Post - Who should get paid for nature's sequenced genes?

EUR -
AED 4.152353
AFN 80.369899
ALL 98.473717
AMD 441.346329
ANG 2.037499
AOA 1035.543572
ARS 1323.736623
AUD 1.767616
AWG 2.03491
AZN 1.923485
BAM 1.952908
BBD 2.290687
BDT 137.845839
BGN 1.951692
BHD 0.426367
BIF 3374.387324
BMD 1.130506
BND 1.482298
BOB 7.839389
BRL 6.414827
BSD 1.134515
BTN 95.878995
BWP 15.530723
BYN 3.712768
BYR 22157.910267
BZD 2.278905
CAD 1.560239
CDF 3247.942448
CHF 0.935604
CLF 0.027922
CLP 1071.481323
CNY 8.220302
CNH 8.2341
COP 4796.848421
CRC 573.043671
CUC 1.130506
CUP 29.958399
CVE 110.10193
CZK 24.950609
DJF 202.031668
DKK 7.465011
DOP 66.770222
DZD 150.035794
EGP 57.576539
ERN 16.957584
ETB 152.252428
FJD 2.554321
FKP 0.84381
GBP 0.850536
GEL 3.103215
GGP 0.84381
GHS 16.167055
GIP 0.84381
GMD 80.831439
GNF 9826.229229
GTQ 8.73706
GYD 238.077387
HKD 8.769236
HNL 29.441265
HRK 7.537423
HTG 148.218509
HUF 404.49172
IDR 18739.035154
ILS 4.111314
IMP 0.84381
INR 95.645408
IQD 1486.192251
IRR 47608.418476
ISK 145.688108
JEP 0.84381
JMD 179.603198
JOD 0.801754
JPY 162.825564
KES 146.863686
KGS 98.862646
KHR 4541.213825
KMF 491.203857
KPW 1017.412427
KRW 1616.006953
KWD 0.346498
KYD 0.945487
KZT 582.199988
LAK 24528.562646
LBP 101652.045579
LKR 339.615499
LRD 226.903936
LSL 21.125118
LTL 3.338089
LVL 0.683832
LYD 6.192855
MAD 10.515725
MDL 19.474071
MGA 5037.449993
MKD 61.439004
MMK 2373.374199
MNT 4039.612274
MOP 9.064634
MRU 44.892914
MUR 50.963281
MVR 17.420539
MWK 1967.251532
MXN 22.204357
MYR 4.87757
MZN 72.352773
NAD 21.124932
NGN 1817.242257
NIO 41.747983
NOK 11.77815
NPR 153.406114
NZD 1.906236
OMR 0.435457
PAB 1.13452
PEN 4.159739
PGK 4.632078
PHP 63.144955
PKR 318.770265
PLN 4.279098
PYG 9086.582194
QAR 4.135076
RON 4.978069
RSD 117.026674
RUB 92.884341
RWF 1629.75736
SAR 4.240171
SBD 9.452494
SCR 16.15212
SDG 678.866525
SEK 10.946466
SGD 1.48003
SHP 0.8884
SLE 25.763995
SLL 23706.119365
SOS 648.328301
SRD 41.65574
STD 23399.183974
SVC 9.927165
SYP 14698.16681
SZL 21.106366
THB 37.877026
TJS 11.95779
TMT 3.95677
TND 3.369509
TOP 2.647759
TRY 43.521871
TTD 7.684517
TWD 36.279623
TZS 3041.060374
UAH 47.062065
UGX 4155.844844
USD 1.130506
UYU 47.739294
UZS 14673.267654
VES 98.057763
VND 29398.798801
VUV 136.123514
WST 3.129691
XAF 654.975339
XAG 0.035176
XAU 0.000349
XCD 3.055248
XDR 0.814579
XOF 654.989802
XPF 119.331742
YER 276.917357
ZAR 21.080821
ZMK 10175.90214
ZMW 31.567966
ZWL 364.02235
  • CMSC

    -0.2300

    22.01

    -1.04%

  • RBGPF

    63.0000

    63

    +100%

  • RYCEF

    -0.2500

    10

    -2.5%

  • GSK

    0.8800

    39.85

    +2.21%

  • NGG

    -0.0400

    73

    -0.05%

  • RELX

    0.8400

    54.63

    +1.54%

  • BCC

    -1.2200

    93.28

    -1.31%

  • SCS

    -0.0900

    9.92

    -0.91%

  • RIO

    -1.4800

    59.4

    -2.49%

  • VOD

    0.1800

    9.76

    +1.84%

  • CMSD

    -0.0500

    22.3

    -0.22%

  • JRI

    -0.0200

    12.91

    -0.15%

  • BCE

    0.3300

    22.25

    +1.48%

  • AZN

    0.0800

    71.79

    +0.11%

  • BTI

    0.6900

    43.55

    +1.58%

  • BP

    -0.6100

    27.46

    -2.22%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Kolar--TPP